» Articles » PMID: 1312703

Overexpression of H-ras Oncogene Induces Resistance to the Growth-inhibitory Action of Transforming Growth Factor Beta-1 (TGF-beta 1) and Alters the Number and Type of TGF-beta 1 Receptors in Rat Intestinal Epithelial Cell Clones

Overview
Journal Oncogene
Date 1992 Mar 1
PMID 1312703
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

In this report, we utilize rat intestinal cell (IEC-18) clones expressing an activated human H-ras gene to investigate the relationship between malignant transformation and growth control by transforming growth factor beta (TGF-beta). We demonstrate that clones expressing high levels of H-ras oncogene lose sensitivity to the growth inhibitory action of TGF-beta. The loss of sensitivity is related to the degree of H-ras expression and is shown to be a direct consequence of H-ras expression through the use of a clonal cell line with inducible expression of activated H-ras. Co-incident with the loss of growth inhibition, ras-expressing clones display an altered expression of TGF-beta-binding proteins as detectable by [125I]TGF-beta cross-linking. While IEC-18 cells express type II (92 kDa) binding protein predominantly, H-ras expression induces a shift to predominantly type I (69 kDa) binding protein expression.

Citing Articles

RAS oncogenes: weaving a tumorigenic web.

Pylayeva-Gupta Y, Grabocka E, Bar-Sagi D Nat Rev Cancer. 2011; 11(11):761-74.

PMID: 21993244 PMC: 3632399. DOI: 10.1038/nrc3106.


Transformation by oncogenic Ras expands the early genomic response to transforming growth factor beta in intestinal epithelial cells.

Allen C, Du J, Jiang B, Huang Q, Yakovich A, Barnard J Neoplasia. 2008; 10(10):1073-82.

PMID: 18813357 PMC: 2546594. DOI: 10.1593/neo.07739.


Oncogenic Ras and transforming growth factor-beta synergistically regulate AU-rich element-containing mRNAs during epithelial to mesenchymal transition.

Kanies C, Smith J, Kis C, Schmidt C, Levy S, Khabar K Mol Cancer Res. 2008; 6(7):1124-36.

PMID: 18644977 PMC: 2572152. DOI: 10.1158/1541-7786.MCR-07-2095.


HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells.

Wilson C, Cajulis E, Green J, Olsen T, Chung Y, Damore M Breast Cancer Res. 2006; 7(6):R1058-79.

PMID: 16457687 PMC: 1410754. DOI: 10.1186/bcr1343.


Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro.

Brown K, Aakre M, Gorska A, Price J, Eltom S, Pietenpol J Breast Cancer Res. 2004; 6(3):R215-31.

PMID: 15084245 PMC: 400675. DOI: 10.1186/bcr778.